Quarterly report pursuant to Section 13 or 15(d)

STATEMENTS OF CASH FLOWS

v2.4.0.6
STATEMENTS OF CASH FLOWS (USD $)
 3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
OPERATING ACTIVITIES    
Net Income (loss) $ 337,941 $ (16,922)
Adjustments to reconcile net income (loss) to net cash flows used in operating activities:    
Amortization 378,167  
Change in operating assets and liabilities:    
Prepaid expense   875
Accounts receivable (1,275,000)  
Inventory (402,707)  
Accounts payable 280,538 9,591
Net cash flows used in operating activities (681,061) (6,456)
INVESTING ACTIVITIES    
Cash received on acquisition 50,775  
Investment in Kanalife (250,000)  
Net cash flows from investing activities (199,225)  
FINANCING ACTIVITIES    
Proceeds from loan from Roen Ventures 1,080,500  
Proceeds from (repayment of) loan from related party (500) 5,500
Net cash flows from financing activities 1,080,000 5,500
Net increase (decrease) in cash 199,714 (956)
Cash, beginning of period 431 1,168
Cash, end of period 200,145 212
NON CASH TRANSACTION:    
Accounts receivable assumed from acquisitions 396,438  
Inventory assumed from acquisitions 516,500  
Property and equipment assumed from acquisitions 1,288  
Goodwill 34,035,000  
Amount due from PhytoSPHERE agreement (30,500,000)  
Common Shares to be issued for PhytoSPHERE Transaction $ (4,500,000)